Current portfolio is a venn between 3 spheres of Introspection (incl deep thinking, strategy, relationship building), Innovation (incl science, translation, tools) and Impact (incl inclusion, wellbeing economy, impact investment)Strengths: Markets: NZ, India, UK, US, Singapore Sectors: Deep Tech (incl. Biotech, Healthtech, Agritech, Medtech), Pharmaceuticals, Public sector, Financial Services Stage : Conception, Research Commercialisation and Innovation Strategy, Systems TransformationValues: Love (Aroha), Service to Others (Impact), Knowledge (Insights)-----Ipshita has over 15 years' experience across academia, corporates and ministries in biotechnology, health, deep technology and financial services. She started her career in New Zealand and has since worked in the US, UK and India amongst others. She has led strategy, policy and implementation projects in policy development, capacity building, business development, fundraising and transformation. She has been involved in companies with market leading value growth with a strong impact focus. One of her career highlights was co-founding the Global Biotech Revolution / GapSummit - the world’s first inter-generational platform for the bio-economy. To date the summits have brought together over 800 Leaders of Tomorrow from 125 countries to debate with over 300 Leaders of Today, building over 20 ventures that have raised independent funding.In addition, she has worked in McKinsey in the India and NY offices primarily worked in the technology, healthcare and public sector practices. She has led the development of Government of India’s “Digital India 2.0” strategy and was also the Chief of Staff for a M&A deal valued at over 50Bn USD.She has been a speaker or published with Chiasma, NZ Herald, Women in Bio, Foreign Policy, Nasdaq, Nature Careers, The Economist Intelligence Unit, Global BioEconomy Summit, Graduate Women in Science, Lioness Magazine, Impact Alpha, BioScience Investors Inclusion Group amongst others.She currently serves on the advisory committees of Global Biotech Revolution and Chiasma NZ. She was a member of Global Women and UNAIDS HIEx Investors Council. She was also a Visiting Lecturer at the Harvard School of Public Health, University of Cambridge Chemical Engineering & Biotech and Victoria University. Multiple awards include thrice being listed in the 50 Movers and Shakers in Bio Business, St Gallen Leader of Tomorrow, inaugural 40 under 40 for University of Auckland and twice nominated as a Young Global Leader to the World Economic Forum (2024-25)